AllianceBernstein Holding L.P. (AB)

NYSE: AB · Real-Time Price · USD
35.86
+0.12 (0.34%)
At close: Jun 26, 2026, 4:00 PM EDT
35.25
-0.61 (-1.70%)
After-hours: Jun 26, 2026, 7:39 PM EDT
0.34%
Market Cap 3.35B
Revenue (ttm) n/a
Net Income (ttm) 311.04M
Shares Out 93.40M
EPS (ttm) 3.22
PE Ratio 11.13
Forward PE 10.32
Dividend $3.38 (9.43%)
Ex-Dividend Date May 8, 2026
Volume 306,146
Open 35.64
Previous Close 35.74
Day's Range 35.24 - 36.16
52-Week Range 34.92 - 44.11
Beta 0.78
Analysts Hold
Price Target 39.14 (+9.15%)
Earnings Date Jul 23, 2026

About AB

AllianceBernstein Holding L.P. is a publicly owned investment manager. The firm provides its services to investment companies, pension and profit-sharing plans, banks and thrift institutions, trusts, estates, government agencies, charitable organizations, individuals, corporations and other business entities. The firm manages separate client focused portfolios for its clients. The firm primarily invests in common and preferred stocks, warrants and convertible securities, government and corporate fixed-income securities, commodities, currencies... [Read more]

Sector Financials
IPO Date Apr 14, 1988
Employees 4,468
Stock Exchange NYSE
Ticker Symbol AB
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for AB stock is "Hold." The 12-month stock price target is $39.14, which is an increase of 9.15% from the latest price.

Price Target
$39.14
(9.15% upside)
Analyst Consensus: Hold
Stock Forecasts

News

AB Akola Group notification on transactions in the Company's securities by the person discharging managerial responsibilities

AB Akola Group, ISIN code LT0000128092, (hereinafter - the Company), has received a notification from the person discharging managerial responsibilities regarding the transactions in the Company's sec...

8 days ago - GlobeNewsWire

AB Science patent for masitinib in the treatment of metastatic castrate resistant prostate cancer formally granted in the United States with a protection until 2042

PRESS RELEASE AB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION UNTIL 2042 THIS POSITIVE DECISIO...

9 days ago - GlobeNewsWire

AllianceBernstein reports preliminary AUM $899B as of May 31

AllianceBernstein (AB) announced that preliminary assets under management increased to $899B in May, up from $882B at the end of April. The 2% increase in month-end AUM was driven by…

16 days ago - TheFly

AB Announces May 31, 2026 Assets Under Management

NASHVILLE, Tenn., June 10, 2026 /PRNewswire/ -- AllianceBernstein L.P.

16 days ago - PRNewsWire

AllianceBernstein price target lowered to $40 from $42 at Evercore ISI

Evercore ISI lowered the firm’s price target on AllianceBernstein (AB) to $40 from $42 and keeps an Outperform rating on the shares.

18 days ago - TheFly

AllianceBernstein reports preliminary AUM $881B as of April 30

AllianceBernstein (AB) announced that preliminary assets under management increased to $881B in April from $839B at the end of March. The 5% increase in AUM was driven by market appreciation,…

6 weeks ago - TheFly

AB Announces April 30, 2026 Assets Under Management

NASHVILLE, Tenn., May 11, 2026 /PRNewswire/ -- AllianceBernstein L.P.

6 weeks ago - PRNewsWire

AllianceBernstein price target raised to $42 from $41 at Evercore ISI

Evercore ISI raised the firm’s price target on AllianceBernstein (AB) to $42 from $41 and keeps an Outperform rating on the shares.

2 months ago - TheFly

AllianceBernstein price target lowered to $39 from $39.50 at TD Cowen

TD Cowen lowered the firm’s price target on AllianceBernstein (AB) to $39 from $39.50 and keeps a Buy rating on the shares. The firm updated its model following Q1 results…

2 months ago - TheFly

AllianceBernstein price target lowered to $39 from $40 at Barclays

Barclays lowered the firm’s price target on AllianceBernstein (AB) to $39 from $40 and keeps an Equal Weight rating on the shares. The company’s Q1 earnings slightly missed estimates, the…

2 months ago - TheFly

AllianceBernstein Holding Earnings Call Transcript: Q1 2026

Q1 2026 saw resilient results amid volatility, with adjusted EPU up 4% and net revenues rising 4% year-over-year. Despite $6B in net outflows, strong growth in private markets, SMAs, and ETFs offset declines. The Equitable-Corebridge merger and a record $27.5B institutional pipeline position the firm for future growth.

2 months ago - Transcripts

AllianceBernstein Holding Slides: Q1 2026

AllianceBernstein Holding has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 28, 2026.

2 months ago - Filings

AllianceBernstein Holding Earnings release: Q1 2026

AllianceBernstein Holding released its Q1 2026 earnings on April 28, 2026, summarizing the period's financial results.

2 months ago - Filings

AllianceBernstein Holding Quarterly report: Q1 2026

AllianceBernstein Holding has published its Q1 2026 quarterly earnings report on April 28, 2026.

2 months ago - Filings

AllianceBernstein reports Q1 adjusted EPS 83c, consensus 83c

Reports Q1 revenue $1.2B vs. $1.08B last year. “The first quarter of 2026 unfolded against a difficult geopolitical backdrop associated with market volatility,” said Seth Bernstein, CEO of AllianceBer...

2 months ago - TheFly

ALLIANCEBERNSTEIN HOLDING L.P. ANNOUNCES FIRST QUARTER RESULTS

GAAP Net Income of $0.92 per Unit Adjusted Net Income of $0.83 per Unit Cash Distribution of $0.83 per Unit NASHVILLE, Tenn., April 28, 2026 /PRNewswire/ -- AllianceBernstein L.P.

2 months ago - PRNewsWire

AllianceBernstein price target lowered to $40 from $41 at Barclays

Barclays lowered the firm’s price target on AllianceBernstein (AB) to $40 from $41 and keeps an Equal Weight rating on the shares. The firm updated its asset manager models to…

2 months ago - TheFly

AllianceBernstein reports preliminary AUM $839B as of March 31

AllianceBernstein (AB) reported that preliminary assets under management declined to $839B as of March 31, down from $880B at the end of February, driven primarily by market depreciation and, to…

2 months ago - TheFly

AB Announces March 31, 2026 Assets Under Management

NASHVILLE, Tenn., April 13, 2026 /PRNewswire/ -- AllianceBernstein L.P.

2 months ago - PRNewsWire

AllianceBernstein price target lowered to $39.50 from $40 at TD Cowen

TD Cowen lowered the firm’s price target on AllianceBernstein (AB) to $39.50 from $40 and keeps a Hold rating on the shares. The firm adjusted targets in the asset manager,…

2 months ago - TheFly

AB to Report First Quarter 2026 Results on April 28, 2026

NASHVILLE, Tenn., April 6, 2026 /PRNewswire/ -- AllianceBernstein L.P.

2 months ago - PRNewsWire

AllianceBernstein price target lowered to $36 from $40 at BofA

BofA lowered the firm’s price target on AllianceBernstein (AB) to $36 from $40 and keeps a Neutral rating on the shares. The firm reduced targets in the asset managers group…

2 months ago - TheFly

Bernstein Private Wealth Management Appoints Kim Mustin to Lead Fast-Growing Business Owner Segment

― Expanded Leadership Role Highlights Firm's Strategic Commitment to Entrepreneurial Clients ― ― 75% of Bernstein's Wealth Advisors Serve Business Owners ― ― New Business Growth Accelerates, with Q1 2...

3 months ago - PRNewsWire

AllianceBernstein reports preliminary AUM $880B as of February 28

AllianceBernstein (AB) announced that preliminary assets under management increased to $880B during February from $875B at the end of January. The 0.6% increase in month-end AUM was driven by market…

3 months ago - TheFly

AB Announces February 28, 2026 Assets Under Management

NASHVILLE, Tenn., March 11, 2026 /PRNewswire/ -- AllianceBernstein L.P.

3 months ago - PRNewsWire